MNPR: Monopar Therapeutics Financial Statements
Balance sheet, income statement, and cash flow statements for Monopar Therapeutics (MNPR).
$116.11M Market Cap.
MNPR Market Cap. (MRY)
MNPR Shares Outstanding (MRY)
MNPR Assets (MRY)
Total Assets
$60.29M
Total Liabilities
$5.25M
Total Investments
$14.40M
MNPR Income (MRY)
Revenue
$0
Net Income
-$15.59M
Operating Expense
$16.16M
MNPR Cash Flow (MRY)
CF Operations
-$6.40M
CF Investing
-$14.34M
CF Financing
$59.29M
MNPR Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $60,291,071 (720.83%) | $7,345,159 (-44.47%) | $13,226,954 (-35.55%) | $20,521,614 (21.66%) |
Assets Current | $60,291,071 (722.24%) | $7,332,513 (-44.31%) | $13,165,726 (-35.84%) | $20,521,614 (22.15%) |
Assets Non-Current | $0 (0%) | $12,646 (-79.35%) | $61,228 (0%) | $0 (0%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $55,036,771 (884.95%) | $5,587,766 (-44.62%) | $10,089,652 (-46.73%) | $18,941,071 (20.71%) |
Property Plant & Equipment Net | $0 (0%) | $12,646 (-79.35%) | $61,228 (0%) | $0 (0%) |
Cash & Equivalents | $45,816,289 (530.55%) | $7,266,080 (-11.24%) | $8,186,194 (-59.68%) | $20,303,869 (21.31%) |
Accumulated Other Comprehensive Income | $35,992 (354.68%) | -$14,132 (-258.04%) | $8,942 (382.97%) | -$3,160 (59.86%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $14,395,913 (0%) | $0 (0%) | $4,933,550 (0%) | $0 (0%) |
Investments Current | $14,395,913 (0%) | $0 (0%) | $4,933,550 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $2,254,300 (28.28%) | $1,757,393 (-43.83%) | $3,128,894 (97.96%) | $1,580,543 (34.32%) |
Accumulated Retained Earnings (Deficit) | -$75,792,636 (-25.89%) | -$60,206,217 (-16.22%) | -$51,804,021 (-25.47%) | -$41,288,383 (-28.28%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $0 (0%) | $0 (0%) | $8,408 (0%) | $0 (0%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $0 (0%) | $0 (0%) | $8,408 (0%) | $0 (0%) |
Total Liabilities | $5,254,300 (198.98%) | $1,757,393 (-43.98%) | $3,137,302 (98.50%) | $1,580,543 (34.32%) |
Liabilities Current | $5,254,300 (198.98%) | $1,757,393 (-43.83%) | $3,128,894 (97.96%) | $1,580,543 (34.32%) |
Liabilities Non-Current | $0 (0%) | $0 (0%) | $8,408 (0%) | $0 (0%) |
MNPR Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $3,155,735 (-2.33%) | $3,231,042 (9.70%) | $2,945,276 (11.82%) | $2,634,040 (7.79%) |
Research & Development Expense | $13,005,986 (132.24%) | $5,600,193 (-26.23%) | $7,591,601 (16.92%) | $6,493,208 (59.73%) |
Operating Expenses | $16,161,721 (83.01%) | $8,831,235 (-16.19%) | $10,536,877 (15.44%) | $9,127,248 (40.23%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$15,586,419 (-85.50%) | -$8,402,196 (20.10%) | -$10,515,638 (-15.52%) | -$9,103,224 (-44.39%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$15,586,419 (-85.50%) | -$8,402,196 (20.10%) | -$10,515,638 (-15.52%) | -$9,103,224 (-44.39%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$15,586,419 (-85.50%) | -$8,402,196 (20.10%) | -$10,515,638 (-15.52%) | -$9,103,224 (-44.39%) |
Weighted Average Shares | $3,790,202 (-72.58%) | $13,823,951 (8.69%) | $12,718,166 (1.98%) | $12,471,217 (13.81%) |
Weighted Average Shares Diluted | $3,790,202 (-72.58%) | $13,823,951 (8.69%) | $12,718,166 (1.98%) | $12,471,217 (13.81%) |
Earning Before Interest & Taxes (EBIT) | -$15,586,419 (-85.50%) | -$8,402,196 (20.10%) | -$10,515,638 (-15.52%) | -$9,103,224 (-44.39%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$16,161,721 (-83.01%) | -$8,831,235 (16.19%) | -$10,536,877 (-15.44%) | -$9,127,248 (-40.23%) |
MNPR Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$14,338,403 (-390.97%) | $4,927,748 (200.19%) | -$4,918,511 (0%) | $0 (0%) |
Net Cash Flow from Financing | $59,292,257 (2824.80%) | $2,027,227 (6066.85%) | $32,873 (-99.70%) | $10,879,537 (32.97%) |
Net Cash Flow from Operations | -$6,404,139 (18.50%) | -$7,858,293 (-8.71%) | -$7,228,559 (1.21%) | -$7,317,401 (-56.95%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $38,550,209 (4289.72%) | -$920,114 (92.41%) | -$12,117,675 (-439.74%) | $3,566,760 (1.24%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$14,338,403 (-390.97%) | $4,927,748 (200.19%) | -$4,918,511 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $59,396,477 (2763.59%) | $2,074,196 (1794.14%) | $109,506 (-99.00%) | $10,942,790 (33.85%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $494 (102.94%) | -$16,796 (-382.92%) | -$3,478 (-175.22%) | $4,624 (38.69%) |
Share Based Compensation | $1,140,785 (-39.89%) | $1,897,849 (15.63%) | $1,641,263 (11.80%) | $1,468,054 (11.14%) |
Depreciation Amortization & Accretion | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
MNPR Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -84.80% (26.90%) | -116.00% (-49.10%) | -77.80% (-89.29%) | -41.10% (5.95%) |
Return on Average Assets (ROAA) | -75.60% (14.29%) | -88.20% (-31.05%) | -67.30% (-72.56%) | -39.00% (6.25%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -800.60% (22.37%) | -1031.30% (-161.94%) | 1664.90% (82.39%) | 912.80% (-36.65%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -5.35 (-859.32%) | -0.56 (80.46%) | -2.85 (35.07%) | -4.4 (58.33%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 2.11 (133.15%) | 0.91 (-70.03%) | 3.02 (41.52%) | 2.13 (-52.22%) |
Debt to Equity Ratio (D/E) | 0.1 (-69.84%) | 0.32 (1.29%) | 0.31 (274.70%) | 0.08 (10.67%) |
Earnings Per Share (EPS) | -4.11 (-573.77%) | -0.61 (26.51%) | -0.83 (-13.70%) | -0.73 (-25.86%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -1.69 (-197.54%) | -0.57 (0.00%) | -0.57 (3.24%) | -0.59 (-38.12%) |
Book Value Per Share (BVPS) | 14.52 (3494.31%) | 0.4 (-49.05%) | 0.79 (-47.79%) | 1.52 (6.08%) |
Tangible Assets Book Value Per Share (TABVPS) | 15.91 (2895.67%) | 0.53 (-48.94%) | 1.04 (-36.82%) | 1.65 (6.95%) |
Enterprise Value Over EBIT (EV/EBIT) | -7 (0%) | 0 (0%) | -2 (0.00%) | -2 (75.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -7.06 (-13179.63%) | 0.05 (103.51%) | -1.54 (22.52%) | -1.99 (76.04%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 11.47 (175.05%) | 4.17 (-0.86%) | 4.21 (-67.59%) | 12.98 (-9.06%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$6,404,139 (18.50%) | -$7,858,293 (-8.71%) | -$7,228,559 (1.21%) | -$7,317,401 (-56.95%) |
Enterprise Value (EV) | $110,091,428 (24147.72%) | -$457,804 (-102.83%) | $16,172,481 (-10.52%) | $18,074,301 (-65.39%) |
Earnings Before Tax (EBT) | -$15,586,419 (-85.50%) | -$8,402,196 (20.10%) | -$10,515,638 (-15.52%) | -$9,103,224 (-44.39%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$15,586,419 (-85.50%) | -$8,402,196 (20.10%) | -$10,515,638 (-15.52%) | -$9,103,224 (-44.39%) |
Invested Capital | $9,220,482 (649.39%) | -$1,678,314 (-187.40%) | $1,920,274 (240.91%) | -$1,362,798 (-30.40%) |
Working Capital | $55,036,771 (887.19%) | $5,575,120 (-44.45%) | $10,036,832 (-47.01%) | $18,941,071 (21.24%) |
Tangible Asset Value | $60,291,071 (720.83%) | $7,345,159 (-44.47%) | $13,226,954 (-35.55%) | $20,521,614 (21.66%) |
Market Capitalization | $116,111,512 (2195.81%) | $5,057,549 (-83.40%) | $30,468,092 (-24.61%) | $40,415,865 (-42.33%) |
Average Equity | $18,387,755 (153.79%) | $7,245,135 (-46.42%) | $13,520,871 (-39.01%) | $22,168,064 (53.59%) |
Average Assets | $20,613,202 (116.36%) | $9,527,330 (-39.00%) | $15,618,872 (-33.11%) | $23,350,662 (53.96%) |
Invested Capital Average | $1,946,784 (138.96%) | $814,689 (228.99%) | -$631,602 (36.67%) | -$997,285 (-127.90%) |
Shares | 5,277,796 (-64.50%) | 14,866,400 (15.64%) | 12,855,735 (2.11%) | 12,590,612 (9.94%) |
